Literature DB >> 25363001

Convection-enhanced drug delivery: prospects for glioblastoma treatment.

Neil U Barua1, Steven S Gill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25363001      PMCID： PMC6113988          DOI： 10.2217/cns.14.41

Source DB:  PubMed          Journal:  CNS Oncol        ISSN： 2045-0907


× No keyword cloud information.
  20 in total

1.  In vitro and in vivo testing of a novel recessed-step catheter for reflux-free convection-enhanced drug delivery to the brain.

Authors:  T Gill; N U Barua; M Woolley; A S Bienemann; D E Johnson; G Murray; C Fennelly; O Lewis; C Irving; M J Wyatt; P Moore; S S Gill
Journal:  J Neurosci Methods       Date:  2013-07-05       Impact factor: 2.390

2.  Regression of recurrent malignant gliomas with convection-enhanced delivery of topotecan.

Authors:  Jeffrey N Bruce; Robert L Fine; Peter Canoll; Jonathan Yun; Benjamin C Kennedy; Steven S Rosenfeld; Stephen A Sands; Krishna Surapaneni; Rose Lai; Candix L Yanes; Emilia Bagiella; Robert L DeLaPaz
Journal:  Neurosurgery       Date:  2011-12       Impact factor: 4.654

3.  Convection-enhanced delivery of macromolecules in the brain.

Authors:  R H Bobo; D W Laske; A Akbasak; P F Morrison; R L Dedrick; E H Oldfield
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

4.  Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brain mapping.

Authors:  Philippe Schucht; Jürgen Beck; Janine Abu-Isa; Lukas Andereggen; Michael Murek; Kathleen Seidel; Lennard Stieglitz; Andreas Raabe
Journal:  Neurosurgery       Date:  2012-11       Impact factor: 4.654

5.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Authors:  Roger Stupp; Warren P Mason; Martin J van den Bent; Michael Weller; Barbara Fisher; Martin J B Taphoorn; Karl Belanger; Alba A Brandes; Christine Marosi; Ulrich Bogdahn; Jürgen Curschmann; Robert C Janzer; Samuel K Ludwin; Thierry Gorlia; Anouk Allgeier; Denis Lacombe; J Gregory Cairncross; Elizabeth Eisenhauer; René O Mirimanoff
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

6.  Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma.

Authors:  Jiangbing Zhou; Toral R Patel; Rachael W Sirianni; Garth Strohbehn; Ming-Qiang Zheng; Nha Duong; Thomas Schafbauer; Anita J Huttner; Yiyun Huang; Richard E Carson; Ying Zhang; David J Sullivan; Joseph M Piepmeier; W Mark Saltzman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-01       Impact factor: 11.205

7.  Efficacy of antiangiogenic targeted immunotoxin DTAT and DTATEGF against glioblastoma multiforme.

Authors:  Jun Huang; Dun Yuan; Dingyang Liu; Jian Li; Yan Li; Walter A Hall; Bo Li
Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban       Date:  2014-01

8.  Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study.

Authors:  Zvi Lidar; Yael Mardor; Tali Jonas; Raphael Pfeffer; Meir Faibel; Dvora Nass; Moshe Hadani; Zvi Ram
Journal:  J Neurosurg       Date:  2004-03       Impact factor: 5.115

9.  Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study.

Authors:  U Bogdahn; P Hau; G Stockhammer; N K Venkataramana; A K Mahapatra; A Suri; A Balasubramaniam; S Nair; V Oliushine; V Parfenov; I Poverennova; M Zaaroor; P Jachimczak; S Ludwig; S Schmaus; H Heinrichs; K-H Schlingensiepen
Journal:  Neuro Oncol       Date:  2010-10-27       Impact factor: 12.300

10.  YB-1 dependent oncolytic adenovirus efficiently inhibits tumor growth of glioma cancer stem like cells.

Authors:  Klaus Mantwill; Ulrike Naumann; Janina Seznec; Vroni Girbinger; Hermann Lage; Pawel Surowiak; Dagmar Beier; Michel Mittelbronn; Jürgen Schlegel; Per Sonne Holm
Journal:  J Transl Med       Date:  2013-09-18       Impact factor: 5.531
View more
  3 in total

Review 1.  Toward precision medicine in glioblastoma: the promise and the challenges.

Authors:  Michael D Prados; Sara A Byron; Nhan L Tran; Joanna J Phillips; Annette M Molinaro; Keith L Ligon; Patrick Y Wen; John G Kuhn; Ingo K Mellinghoff; John F de Groot; Howard Colman; Timothy F Cloughesy; Susan M Chang; Timothy C Ryken; Waibhav D Tembe; Jeffrey A Kiefer; Michael E Berens; David W Craig; John D Carpten; Jeffrey M Trent
Journal:  Neuro Oncol       Date:  2015-05-01       Impact factor: 12.300

2.  Brain microglia activation induced by intracranial administration of oligonucleotides and its pharmacological modulation.

Authors:  Sebastiano La Maestra; Guido Frosina; Rosanna T Micale; Chiara D'Oria; Silvano Garibaldi; Antonio Daga; Alessandra Pulliero; Alberto Izzotti
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

Review 3.  Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments.

Authors:  Panchanan Maiti; Jayeeta Manna; Gary L Dunbar
Journal:  Transl Neurodegener       Date:  2017-10-25       Impact factor: 8.014
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.